drugset / Trial / NCT01957995
Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
13 enrolled
University of Southern California
Jina Pharmaceuticals Inc. · collabNational Cancer Institute (NCI) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomized phase I trial studies the side effects and best dose of nanosomal docetaxel lipid suspension in treating patients with advanced solid tumors. Drugs used in chemotherapy, such as nanosomal docetaxel lipid suspension, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Timeline
- Start
- 2013-11-08
- Primary completion
- 2014-05-29
- Completion
- 2016-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |